Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT

Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT

Background: Around one-third of pregnant women suffer from moderate to severe nausea and vomiting, causing physical and emotional distress and reducing their quality of life. There is no cure for nausea and vomiting in pregnancy. Management focuses on relieving symptoms and preventing morbidity, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephen Robson, Catherine McParlin, Helen Mossop, Mabel Lie, Cristina Fernandez-Garcia, Denise Howel, Ruth Graham, Laura Ternent, Alison Steel, Nicola Goudie, Afnan Nadeem, Julia Phillipson, Manjeet Shehmar, Nigel Simpson, Derek Tuffnell, Ian Campbell, Rew Williams, Margaret E O’Hara, Elaine McColl, Catherine Nelson-Piercy
Formato: article
Lenguaje:EN
Publicado: NIHR Journals Library 2021
Materias:
emesis in pregnancy
ondansetron
metoclopramide
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/2c1261229c1949d0abcabb7b2b13602d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2c1261229c1949d0abcabb7b2b13602d

Ejemplares similares